Syndax Pharmaceuticals (SNDX) News Today $15.74 +1.01 (+6.86%) Closing price 04:00 PM EasternExtended Trading$15.88 +0.15 (+0.92%) As of 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock SNDX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Syndax Pharmaceuticals (SNDX) Is Up 15.8% After Revenue Surges in Q2 2025 Results Has Sentiment Shifted?August 15 at 5:36 AM | finance.yahoo.comAigen Investment Management LP Buys Shares of 24,158 Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)August 15 at 5:00 AM | marketbeat.comInvestors Purchase Large Volume of Call Options on Syndax Pharmaceuticals (NASDAQ:SNDX)August 14 at 2:11 AM | americanbankingnews.comSyndax Pharmaceuticals: A Tale Of Two Drug LaunchesAugust 13 at 7:14 PM | seekingalpha.comSyndax Pharmaceuticals Sees Unusually Large Options Volume (NASDAQ:SNDX)August 13 at 10:51 AM | marketbeat.comFDA Priority Review and Revenue Growth Drive Short-Term Upswing for Syndax PharmaceuticalsAugust 13 at 2:17 AM | insidermonkey.comAnalysts Set Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) PT at $36.91August 13 at 2:15 AM | americanbankingnews.comSyndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Average Recommendation of "Buy" by BrokeragesAugust 11, 2025 | marketbeat.comAnalysts Just Made A Dazzling Upgrade To Their Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) ForecastsAugust 10, 2025 | finance.yahoo.comWhat is B. Riley's Forecast for SNDX Q3 Earnings?August 10, 2025 | americanbankingnews.comSyndax Pharmaceuticals’ Earnings Call Highlights Robust GrowthAugust 9, 2025 | theglobeandmail.comSyndax Pharmaceuticals (SNDX) Gets a Buy from Goldman SachsAugust 9, 2025 | theglobeandmail.comQ3 Earnings Forecast for SNDX Issued By B. RileyAugust 9, 2025 | marketbeat.comSyndax Pharmaceuticals (NASDAQ:SNDX) Stock Rating Upgraded by B. RileyAugust 8, 2025 | marketbeat.comSyndax Pharmaceuticals (NASDAQ:SNDX) Price Target Raised to $56.00August 7, 2025 | americanbankingnews.comSyndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Expected to Rise, Citigroup Analyst SaysAugust 7, 2025 | americanbankingnews.comSyndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Q2 2025 Earnings Call TranscriptAugust 6, 2025 | msn.comSyndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)August 6, 2025 | globenewswire.comCitigroup Forecasts Strong Price Appreciation for Syndax Pharmaceuticals (NASDAQ:SNDX) StockAugust 6, 2025 | marketbeat.comBTIG Research Raises Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target to $56.00August 6, 2025 | marketbeat.comSyndax Pharmaceuticals (NASDAQ:SNDX) Shares Gap Up After Earnings BeatAugust 6, 2025 | marketbeat.comSyndax Pharmaceuticals (NASDAQ:SNDX) Announces Earnings ResultsAugust 5, 2025 | marketbeat.comSyndax jumps after Q2 beat; Citi issues upside catalyst watchAugust 5, 2025 | msn.comSyndax Pharmaceuticals: The Story BrightensAugust 5, 2025 | seekingalpha.comSyndax (SNDX) Q2 Revenue Jumps 986%August 5, 2025 | theglobeandmail.comSyndax Pharmaceuticals, Inc. (SNDX) Q2 2025 Earnings Call TranscriptAugust 4, 2025 | seekingalpha.comSyndax Pharmaceuticals, Inc. 2025 Q2 - Results - Earnings Call PresentationAugust 4, 2025 | seekingalpha.comSyndax Reports Second Quarter 2025 Financial Results and Provides Business UpdateAugust 4, 2025 | globenewswire.comXTX Topco Ltd Invests $783,000 in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)August 4, 2025 | marketbeat.comSyndax Pharmaceuticals Q2 2025 Earnings PreviewAugust 2, 2025 | msn.comGSA Capital Partners LLP Buys 50,427 Shares of Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)August 1, 2025 | marketbeat.comSyndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Up 6.2% - Should You Buy?July 30, 2025 | marketbeat.comSyndax to Announce Second Quarter 2025 Financial Results and Host Conference Call and Webcast on August 4, 2025July 28, 2025 | globenewswire.comSyndax Pharmaceuticals, Inc. (NASDAQ:SNDX) CFO Sells $12,039.84 in StockJuly 19, 2025 | marketbeat.comSyndax Pharmaceuticals, Inc. (NASDAQ:SNDX) CEO Sells $69,990.86 in StockJuly 19, 2025 | marketbeat.comSyndax Pharmaceuticals, Inc. (NASDAQ:SNDX) CFO Keith A. Goldan Sells 1,296 SharesJuly 19, 2025 | insidertrades.comVienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group Makes New $2.46 Million Investment in Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX)July 18, 2025 | marketbeat.comSyndax Pharmaceuticals (NASDAQ:SNDX) Shares Down 6% on Analyst DowngradeJuly 15, 2025 | marketbeat.comSyndax Pharmaceuticals (NASDAQ:SNDX) Price Target Cut to $35.00 by Analysts at UBS GroupJuly 15, 2025 | marketbeat.com3 ‘Strong Buy’ Russell 2000 Stocks with Triple-Digit Upside PotentialJuly 12, 2025 | msn.comThe Goldman Sachs Group Initiates Coverage on Syndax Pharmaceuticals (NASDAQ:SNDX)July 10, 2025 | marketbeat.comSyndax Pharmaceuticals (NASDAQ:SNDX) Shares Up 6.7% - Time to Buy?July 9, 2025 | marketbeat.comSyndax’s Revuforj Granted FDA Priority Review for Relapsed/Refractory Mutant NPM1 AMLJuly 9, 2025 | msn.comSyndax Pharmaceuticals: Oversold Pharma Likely To Benefit From Drug ApprovalsJuly 8, 2025 | seekingalpha.comSyndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635 (c) (4) - MorningstarJuly 3, 2025 | morningstar.comMSyndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)July 2, 2025 | globenewswire.comSyndax Pharmaceuticals, Inc. (SNDX) - Yahoo FinanceJune 27, 2025 | finance.yahoo.comSNDX Syndax Pharmaceuticals, Inc. - Seeking AlphaJune 26, 2025 | seekingalpha.comSyndax Pharmaceuticals Inc News (SNDX) - Investing.comJune 26, 2025 | investing.comSyndax Announces FDA Priority Review of sNDA for Revuforj® (revumenib) in Relapsed or Refractory mNPM1 Acute Myeloid Leukemia - MorningstarJune 25, 2025 | morningstar.comM Get Syndax Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SNDX and its competitors with MarketBeat's FREE daily newsletter. Email Address SNDX Media Mentions By Week SNDX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SNDX News Sentiment▼0.810.61▲Average Medical News Sentiment SNDX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SNDX Articles This Week▼176▲SNDX Articles Average Week Get Syndax Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for SNDX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MRUS News CYTK News AKRO News PTCT News ADMA News TLX News ACAD News KRYS News PCVX News ACLX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SNDX) was last updated on 8/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Syndax Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Syndax Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access